Abstract
Objective: Cancer patients who smoke are advised to quit smoking to reduce treatment complications and future cancer risk. This study's main objective was to evaluate the efficacy of a novel, presurgical cessation intervention in newly diagnosed cancer patients scheduled for surgical hospitalization. Method: We conducted a parallel-arm, randomized controlled trial comparing the efficacy of our hospital-based, tobacco cessation "best practices" treatment model (BP; cessation counseling and nicotine replacement therapy) with BP enhanced by a behavioral tapering regimen (scheduled reduced smoking; BP + SRS) administered by a handheld computer before hospitalization for surgery. Cessation outcomes were short (hospital admission and 3 months) and longer-term (6 months) biochemically verified smoking abstinence. We hypothesized that BP + SRS would be superior to BP alone. One hundred eighty-five smokers were enrolled. Results: Overall, 7-day-point prevalence, confirmed abstinence rates at 6 months for BP alone (32%) and BP + SRS (32%) were high; however, no main effect of treatment was observed. Patients who were older and diagnosed with lung cancer were more likely to quit smoking. Conclusion: Compared to best practices for treating tobacco dependence, a presurgical, scheduled reduced smoking intervention did not improve abstinence rates among newly diagnosed cancer patients.
Original language | English (US) |
---|---|
Pages (from-to) | 737-747 |
Number of pages | 11 |
Journal | Health Psychology |
Volume | 33 |
Issue number | 7 |
DOIs | |
State | Published - Jul 2014 |
Keywords
- Hospitalized smokers
- Patients with cancer
- Scheduled reduced smoking
- Smoking cessation
ASJC Scopus subject areas
- Applied Psychology
- Psychiatry and Mental health
MD Anderson CCSG core facilities
- Clinical Trials Office